Your browser doesn't support javascript.
loading
Response to (K)RASG12C and EGFR Inhibition in a Patient With NRASG12C-Mutated Rectal Cancer.
Möhrmann, Lino; Cuberi, Ani; Brückmann, Sascha; Stasik, Sebastian; Heukamp, Lukas C; Bornhäuser, Martin; Glimm, Hanno; Folprecht, Gunnar.
Afiliação
  • Möhrmann L; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
  • Cuberi A; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brückmann S; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Stasik S; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
  • Heukamp LC; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Bornhäuser M; German Cancer Consortium (DKTK), Dresden, Germany.
  • Glimm H; Department of Radiology, University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden, Dresden, Germany.
  • Folprecht G; Department of Pathology, University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden, Dresden, Germany.
JCO Precis Oncol ; 7: e2200666, 2023 05.
Article em En | MEDLINE | ID: mdl-37262393

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais Limite: Humans Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais Limite: Humans Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2023 Tipo de documento: Article